Bridgewater Associates LP Reduces Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Bridgewater Associates LP cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 19.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,232 shares of the company’s stock after selling 3,772 shares during the period. Bridgewater Associates LP’s holdings in Acadia Healthcare were worth $966,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. William Blair Investment Management LLC boosted its position in shares of Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after buying an additional 604,070 shares during the last quarter. Point72 Asset Management L.P. boosted its position in Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Acadia Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after purchasing an additional 77,509 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Acadia Healthcare by 2.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,127,061 shares of the company’s stock worth $71,467,000 after purchasing an additional 29,936 shares during the last quarter. Finally, Millennium Management LLC boosted its position in Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after purchasing an additional 1,055,894 shares during the last quarter.

Acadia Healthcare Stock Down 1.6 %

Shares of ACHC opened at $40.63 on Monday. The business’s 50 day moving average is $50.46 and its 200 day moving average is $63.52. The company has a market capitalization of $3.77 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.80 and a beta of 1.33. Acadia Healthcare Company, Inc. has a 12-month low of $36.50 and a 12-month high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same quarter last year, the company earned $0.91 EPS. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. Research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ACHC has been the topic of several research reports. Royal Bank of Canada dropped their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Barclays lowered their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Finally, KeyCorp initiated coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $79.67.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.